Sweden· SE-20240725000082
Safinamide STADA 100 mg Filmdragerad tablett
A safinamide product containing safinamide, registered in Sweden by STADA Arzneimittel AG. The same ATC class is registered in 17 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Safinamide is registered in 17 of 19 countries.
Countries holding a registration under ATC N04BD03 (safinamide), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 10 of them publish a price we can compare per daily dose
Safinamide · ATC N04BD03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of safinamide costs, country by country.
Normalised to the WHO defined daily dose (75 mg), the median price runs from $2.78 in Spain to $5.29 in Italy — a ×1.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Safinamide · price per daily dose (75 mg)
USD · FX 28 Sept 2026
- IT Italy$5.29
- CH Switzerland$4.79
- ES Spain$2.78
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Safinamide
- Manufacturer
- STADA Arzneimittel AG
- Country
- Sweden (SE)
- ATC code
- N04BD03
- ATC class
- Safinamide
- Defined daily dose
- 75 mg, O
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20240725000082
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
158 interactions on record for safinamide.
Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Safinamide · interactions on record
158 records
- 18 severe
- 140 moderate
Most severe, free to view
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
- SibutramineA08AA10severe
- DoxepinD04AX01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Safinamide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSAFINAMIDA AUROVITAS 100 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFGAurovitas Spain, S.A.U.
- CzechiaXADAGOZambon S.p.A., Bresso
- BelgiumSafinamide AB 100 mgAurobindo
- United StatesXadagoMDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
- SwitzerlandXadago 100 mg, compresse rivestite con filmZambon Svizzera SA
- FinlandSafinamide VivantaVivanta Generics s.r.o.
- NetherlandsSafinamide Vivanta 100 mg filmomhulde tablettenVivanta Generics s.r.o.
- NorwayXadagoZambon SpA
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Belgium · Safinamide Ab, Safinamide Eg
- Cyprus · Orvago
- Germany · Safinamid Al, Safinamid Puren
- Denmark · Safinamid Vivanta
- Estonia · Safinamide Teva
- Spain · Safinamida Aurovitas, Safinamida Cinfa
- Finland · Safinamide Vivanta
- United Kingdom (Northern Ireland) · Safinamide Amarox, Safinamide Milpharm
- Greece · Orvago, Safinamide Win Medica
- Croatia · Safinamid Msn, Safinamide Msn
- Iceland · Xadago
- Italy · Safinamide Aurobindo, Safinamide Doc
- Liechtenstein · Xadago
- Lithuania · Safinamide Teva
- Luxembourg · Safinamide Eg
- Latvia · Safinamide Teva
- Malta · Safinamide Nio
- Netherlands · Safinamide Vivanta
- Norway · Safinamide Vivanta, Xadago
- Portugal · Safinamida Aurobindo, Safinamida Generis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ea4ddc1d-405e-48cd-adeb-9cf03dcf531a GET /v1/drugs/ea4ddc1d-405e-48cd-adeb-9cf03dcf531a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20240725000082",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240725000082",
"product_doc_link": "https://docetp.mpa.se/LMF/Safinamide%20STADA%20film-coated%20tablet%20SmPC_09001bee84d496e4.pdf"
}See everything about safinamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.